Can serum glial fibrillary acidic protein (GFAP) solve the longstanding problem of diagnosis and monitoring progressive multiple sclerosis

被引：2
作者：
Groen, Kira [1 ,2 ]
Lechner-Scott, Jeannette [1 ,2 ]
Pohl, Daniela [3 ]
Levy, Michael [4 ]
Giovannoni, Gavin [5 ]
Hawkes, Chris [6 ]
机构：
[1] Univ Newcastle, Hunter Med Researc Inst, Newcastle, NSW, Australia
[2] Hunter New England Area Hlth, Newcastle, NSW, Australia
[3] Univ Ottawa, Ottawa, ON, Canada
[4] Harvard Univ, Cambridge, MA 02138 USA
[5] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Dept Neurol, London, England
[6] Queen Mary Univ London, Dept Neurol, Neurosci Ctr, London, England
来源：
MULTIPLE SCLEROSIS AND RELATED DISORDERS | 2021年 / 50卷
关键词：
WHITE-MATTER LESIONS; NEUROMYELITIS-OPTICA; SPECTRUM;
D O I：
10.1016/j.msard.2021.102931
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 28 条
  • [11] Comparing Glial Fibrillary Acidic Protein (GFAP) in Serum and Plasma Following Mild Traumatic Brain Injury in Older Adults
    Huebschmann, Nathan A.
    Luoto, Teemu M.
    Karr, Justin E.
    Berghem, Ksenia
    Blennow, Kaj
    Zetterberg, Henrik
    Ashton, Nicholas J.
    Simren, Joel
    Posti, Jussi P.
    Gill, Jessica M.
    Iverson, Grant L.
    [J]. FRONTIERS IN NEUROLOGY, 2020, 11
  • [12] A Score Based on NfL and Glial Markers May Differentiate Between Relapsing-Remitting and Progressive MS Course
    Huss, Andre
    Otto, Markus
    Senel, Makbule
    Ludolph, Albert C.
    Abdelhak, Ahmed
    Tumani, Hayrettin
    [J]. FRONTIERS IN NEUROLOGY, 2020, 11
  • [13] Multiple sclerosis with and without CSF bands: Clinically indistinguishable but immunogenetically distinct
    Imrell, Kerstin
    Landtblom, Anne-Marie
    Hillert, Jan
    Masterman, Thomas
    [J]. NEUROLOGY, 2006, 67 (06) : 1062 - 1064
  • [14] Evaluation of MS related central fatigue using MR neuroimaging methods: Scoping review
    Jameen, A. R. M.
    Ribbons, Karen
    Lechner-Scott, Jeannette
    Ramadan, Saadallah
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 400 : 52 - 71
  • [15] Aquaporin-4 Antibodies (NMO-IgG) as a Serological Marker of Neuromyelitis Optica: A Critical Review of the Literature
    Jarius, Sven
    Wildemann, Brigitte
    [J]. BRAIN PATHOLOGY, 2013, 23 (06) : 661 - 683
  • [16] Cerebrospinal fluid biomarkers of white matter lesions - cross-sectional results from the LADIS study
    Jonsson, M.
    Zetterberg, H.
    van Straaten, E.
    Lind, K.
    Syversen, S.
    Edman, A.
    Blennow, K.
    Rosengren, L.
    Pantoni, L.
    Inzitari, D.
    Wallin, A.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 (03) : 377 - 382
  • [17] Neurofilaments as biomarkers in neurological disorders
    Khalil, Michael
    Teunissen, Charlotte E.
    Otto, Markus
    Piehl, Fredrik
    Sormani, Maria Pia
    Gattringer, Thomas
    Barro, Christian
    Kappos, Ludwig
    Comabella, Manuel
    Fazekas, Franz
    Petzold, Axel
    Blennow, Kaj
    Zetterberg, Henrik
    Kuhle, Jens
    [J]. NATURE REVIEWS NEUROLOGY, 2018, 14 (10) : 577 - 589
  • [18] Blood neurofilament light chain as a biomarker of MS disease activity and treatment response
    Kuhle, Jens
    Kropshofer, Harald
    Haering, Dieter A.
    Kundu, Uma
    Meinert, Rolf
    Barro, Christian
    Dahlke, Frank
    Tomic, Davorka
    Leppert, David
    Kappos, Ludwig
    [J]. NEUROLOGY, 2019, 92 (10) : E1007 - E1015
  • [19] Menopause and multiple sclerosis: Influence on prognosis and role of disease-modifying drugs and hormonal replacement therapy
    Midaglia, Luciana
    Otero, Susana
    Baro, Francesc
    Montalban, Xavier
    Tintore, Mar
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (02) : 173 - 182
  • [20] GFAP in health and disease
    Middeldorp, J.
    Hol, E. M.
    [J]. PROGRESS IN NEUROBIOLOGY, 2011, 93 (03) : 421 - 443
123